Ultragenyx Pharmaceuticals, Inc. (NASDAQ:RARE): From Peak Burn To Profitability

Initiation on Ultragenyx focused on the transition from peak burn to profitability—balancing commercial durability, pipeline optionality, and the timing of margin inflection.